Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps ...

Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity ...

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

Rick Modi’s background in pharmacy gave him the scientific and analytical chops to pursue an MBA and ultimately lead innovative gene therapy companies.

The treatment landscape for autoimmune and inflammatory diseases has evolved through three distinct phases. The first era, dating back as far as the 1960s, relied on broad immunosuppressants such as ...

In this episode, Host Erin Harris sits down with Dr. Simrit Parmar, Founder of Cellenkos, to explore how the company is pioneering umbilical cord blood-derived Regulatory T cell (Treg) cell therapies ...